卵巢组织移植评估:三个临床中心的结果
该多中心回顾性队列研究纳入60例在绝育治疗前冻存卵巢组织并返回接受自体移植的不孕患者,共进行70次移植;移植后94%患者月经恢复,中位FSH从68 IU/mL降至19 IU/mL,50%患者至少获得一次妊娠,41.6%至少获得一次活产;结论认为卵巢组织冻存能高效恢复绝育患者的生育力,既往化疗不应视为禁忌,移植物功能异常时可考虑重复移植。
要点
- 移植后94%患者月经恢复,中位FSH从68 IU/mL降至19 IU/mL。
- 50%患者至少获得一次妊娠,41.6%至少获得一次活产。
- 既往化疗与较差结局无关;7例盆腔放疗暴露者中4例妊娠并分娩。
核心结论
- 卵巢组织冻存能高效恢复绝育患者的生育力。
- 既往化疗不应视为卵巢组织自体移植的禁忌。
- 移植物功能异常时可考虑重复自体移植,尤其此前移植成功者。
- 在选定病例中,盆腔放疗暴露后妊娠和分娩可能可行。
研究设计与样本
- 多中心回顾性队列研究,设置于三级医疗中心。
- 2004年至2018年间,70例患者接受了87次卵巢组织自体移植。
- 60例患者共70次移植符合纳入标准,均为绝育治疗前冻存卵巢组织并返回接受自体移植以追求妊娠的不孕患者。
- 干预包括卵巢组织冻存与自体移植、内分泌监测及体外受精。
主要发现
- 移植后94%患者月经恢复,中位FSH从68 IU/mL降至19 IU/mL。
- 共获得50次妊娠和44次分娩,50%女性至少获得一次妊娠,41.6%至少获得一次分娩。
- 12例患者接受不止一次自体移植,若首次移植后月经再次出现则内分泌活动恢复。
- 重复移植在3例患者中产生5次活产,其中2例已在首次移植后分娩。
- 采集前化疗与较差结局无关;7例移植前盆腔接受放疗者中4例妊娠并分娩。
临床怎么用
- 作者认为卵巢组织冻存能高效恢复绝育患者的生育力。
- 作者认为既往化疗不应视为禁忌。
- 作者建议移植物功能异常时可考虑重复自体移植,尤其此前移植成功者。
- 作者认为在选定病例中,盆腔放疗暴露后妊娠和分娩可能可行。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To report ovarian tissue autotransplantation (AT) results and describe the relationship between technical and clinical factors and outcomes. DESIGN: Multicenter retrospective cohort study. SETTING: Tertiary medical centers. PATIENT(S): Infertile patients who had stored ovarian tissue before sterilizing treatment and returned for AT with the aim of conceiving. INTERVENTIONS(S): Ovarian tissue cryopreservation (OTC) and AT, endocrine monitoring, in vitro fertilization. MAIN OUTCOME MEASURE(S): Endocrine performance, pregnancy and live-birth rates. RESULT(S): From 2004 to 2018, 70 patients underwent 87 ATs. Sixty patients undergoing 70 ATs met the inclusion criteria. After AT, menses returned in 94% of patients and median FSH dropped from 68 to 19 IU/mL. Fifty pregnancies and 44 deliveries were attained, with 50% of women achieving at least one pregnancy and 41.6% at least one delivery. Twelve patients underwent AT more than once and had their endocrine activity restored in case menses recurred after the first transplantation. Repeated transplantations yielded five live births in three patients, two of whom had already given birth after the first transplantation. Preharvesting chemotherapy was not associated with inferior outcomes. Of seven patients whose pelvis was exposed to radiation before AT, four conceived and delivered. Neither tissue dimensions nor surgical approach affected fertility outcomes. CONCLUSION(S): OTC is highly effective at restoring fertility in sterilized patients, and prior exposure to chemotherapy should not be considered a contraindication. Repeated AT should be contemplated in case of graft malfunction, especially if previous transplantation was successful. In selected cases, conception and delivery may be feasible after pelvic exposure to radiation.
引用
- Shapira M, Dolmans MM, Silber S, et al. Evaluation of ovarian tissue transplantation: results from three clinical centers. Fertil Steril. 2020. PMID: 32605799. doi:10.1016/j.fertnstert.2020.03.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。